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INTRODUCTION 
 
One of the most widely-discussed issues regarding reproductive management of 
dairy cows is the historic decline in fertility for lactating cows that began about 1960. It is 
important to recognize that this situation is being reversed and there has been a steady 
increase in reproductive function in the last several years (Figure 1). Genetically, the dairy 
cow is still less fertile than the cow of 50 years ago: the predicted transmitting ability (PTA) 
of a Holstein bull for daughter pregnancy rate (DPR) in 1965 was +7.1 vs a PTA of +1.4 
in 2015. Nonetheless, genetic merit for fertility has been increasing: the nadir for bull PTA 
for DPR (-1.1) in Holsteins was experienced in 2002. The improvement in genetic merit 
has involved increased emphasis on health and reproduction traits in leading selection 
indices like net merit. Fertility has also improved in recent years because of the 
incorporation of timed artificial insemination (AI) programs in reproductive management 
systems. Initially, these programs were designed to avoid problems inherent in estrus 
detection. Now, however, refinements in timed AI programs to optimize the endocrine 
environment of the cow mean that fertility to timed AI can exceed that following AI at 
detected estrus (Santos et al., 2017). 
 
While difficult to document, it is likely that increased management emphasis on 
cow comfort has also contributed to the increase in reproductive function of lactating 
cows. Indeed, as will be shown in this paper, health is closely connected to resumption 
of estrous cycles after calving, pregnancy rate per insemination once estrous cyclicity has 
resumed and maintenance of a pregnancy after a cow is diagnosed pregnant.  
 
The connection between health, immune function and reproductive function is 
complex and not fully understood.  A schematic diagram illustrating some mechanisms 
by which inflammation and immune activation cause disruption in reproductive function is 
shown in Figure 2.  
 
Activation of the inflammatory response by local tissue damage (due to injury, 
ischemia, exposure to noxious molecules, etc.) or by viral or bacterial infection leads to 
the release of a variety of biologically-active molecules such as cytokines, chemokines, 
and prostaglandins that assist in tissue repair and promote activation of immune 
responses that in turn involve synthesis and release of additional cytokines.   Biologically-
active products of inflammation and the immune system can act at sites distant from the 
site of tissue injury. For example, specific cytokines affect the hypothalamus to increase 
body temperature which is damaging to the oocyte and embryo (Hansen, 2014). 
Additionally, inflammatory signals can reduce appetite and alter metabolism of 
carbohydrates, fat and protein (Gifford et al., 2010).  Immune responses also increase 
energy utilization although the magnitude of this increase in cattle is unclear. Resultant 
changes in energy balance associated with inflammation make it more difficult for cows 
to resume estrous cycles after calving because the length of the postpartum anestrus is 
related to energy status (Crowe, 2008). Other actions of cytokines on the hypothalamic-
pituitary axis cause inhibition of release of the gonadotropins necessary for establishment 
and maintenance of estrous cyclicity. Specific cytokines can disrupt the function of the 
oocyte and developing embryo (see for example, the negative effects of tumor necrosis 
factor-; Soto et al., 2003). Molecules released by microorganisms, particularly those, 
like bacterial lipopolysaccharides, that activate toll-like receptors on mammalian cells, can 
act directly on the ovary to affect follicular development and oocyte function (Bromfield 
and Sheldon, 2011, 2013) and on the endometrium to increase secretion of 
prostaglandins, cytokines and chemotactic agents that disrupt uterine function and the 
local environment of the embryo (MacKintosh et al., 2013).  Perturbation of the local 
environment is particularly likely when bacterial infection is ongoing in the uterus itself 
(Bromfield et al., 2015). 
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Figure 1. Changes in daughter pregnancy rate and milk yield in US Holsteins from 2005-
2015 based on records maintained by the Council on Dairy Cattle Breeding 
(https://www.uscdcb.com/eval/summary/trend.cfm). Note that daughter 
pregnancy rate is the proportion of a bull’s daughters eligible to be pregnant in 
a 21-day period that are pregnant. It is determined by a combination of the 
proportion of cows that are bred and the proportion of bred cows that become 
pregnant.   
 
 
Figure 2. Simplified cartoon to describe some of the mechanisms by which disease and 
activation of the inflammatory and immune systems can compromise 
reproductive function in the cow. Red arrows indicate pathways leading to 
disruption of the reproductive system.  
 
Given the nexus between the immune, inflammatory and reproductive systems, 
approaches to improve dairy cow health should also result in improved reproductive 
function. Given this reasoning, there are two goals of the current paper. The first is to 
show some of the evidence that health and immune function is related to reproductive 
function. The second goal is to review some recent studies that evaluated prospects for 
improving cow fertility through regulation of immune function.  
 
EVIDENCE THAT DISEASE IS ASSOCIATED WITH REDUCED 
REPRODUCTIVE FUNCTION 
 
Probably the best evidence that a host of disease events compromise reproduction 
in postpartum cows is derived from studies conducted at the University of Florida by José 
Santos, Edward Ribeiro, and colleagues. The approach was to classify individual cows 
as to incidence of specific diseases and then compare reproductive function of cows 
without disease to those experiencing one or more diseases.  
 
Selected results from two of these studies are summarized in Table 1.  In the first 
experiment (Santos et al., 2010), a total of 5,709 cows were examined. Resumption of 
estrous cycles, as determined by the percent of cows that were cyclic at day 65 
postpartum, was not affected by a single occurrence of disease. However, fewer cows 
experiencing more than one disease were cyclic at day 65 than cows not experiencing 
disease. Pregnancy rate at first AI was reduced if cows experienced one disease and was 
even lower when cows experienced more than one disease.  A wide range of diseases 
were associated with a significant reduction in reproductive function. For example, 
pregnancy rate at first AI was reduced from 51.4% in cows without disease to 40.3% for 
cows with calving problems, 37.8% for cows with metritis, 38.7% for cows with clinical 
endometritis, 39.8% for cows with fever postpartum, 28.8% for cows with clinical ketosis, 
and 33.3% for cows with lameness.  
 
Table 1.  Association of disease incidents in the postpartum period with resumption of 
cyclicity and fertility at first insemination.   
Study Number 
and type 
of cows  
Health 
status 
Endpoint Value Adjusted 
odds 
ratio  
P 
Santos et 
al., 2010 
5719 
cows on 7 
dairies 
     
  Healthy % cyclic at day 65 
postpartum 
84.1 1.00 -- 
  1 case of 
disease 
 80.0 0.97 0.83 
  > 1 case of 
disease 
 70.7 0.60 0.001 
  Healthy % pregnant at first 
AI 
51.4 1.00 -- 
  1 case of 
disease 
 43.3 0.79 0.001 
  > 1 case of 
disease 
 34.7 0.57 <0.001 
       
Ribeiro et 
al., 2013 
957 cows 
on 2 
grazing 
dairies 
     
  No disease % cyclic at day 49 
postpartum 
91.1 1.00 -- 
  1 clinical 
disease 
 88.3 0.74 0.22 
  > 1 clinical 
disease 
 
 77.8 0.34 <0.01 
  No disease % pregnant at first 
AI  
66.9 1.00 -- 
  1 clinical 
disease 
 56.5 0.64 <0.01 
  > 1 clinical 
disease 
 40.8 0.34 <0.01 
 
Similar findings were obtained in a second study of 957 cows on two seasonal 
grazing dairies (Ribeiro et al., 2013). Again, more than 1 clinical disease was associated 
with reduced cyclicity while even a single clinical disease was associated with reduced 
pregnancy rate at first AI (Table 1).  The diseases associated with reduced pregnancy 
rate at first AI were calving problems, metritis, clinical endometritis, and digestive 
problems. There was also a tendency (P<0.10) for pregnancy rate to be lower for cows 
with mastitis or lameness.  
 
In a recent study, Ribeiro et al. (2016) used records from 5,085 cows to evaluate 
whether the impact of uterine disease (metritis and retained placenta) on postpartum 
reproductive function was greater than the impact of other diseases (including mastitis, 
digestive problems, pneumonia, and lameness). The reduction in pregnancy rate at day 
45 after breeding (via AI or embryo transfer) and calving rate after the first breeding 
postpartum was similar for cows with uterine disease vs those with other diseases. Cows 
that had both types of disease were less fertile than cows that experienced one kind of 
disease only.  Both types of disease also increased pregnancy loss after cows were 
confirmed pregnant at day 45 after breeding.  Santos et al. (2010) and Ribeiro et al. (2013) 
also noted association of disease with increased pregnancy loss.  
 
Ribeiro et al. (2016) found that disease reduced pregnancy rate for both cows that 
were bred by AI and those that received an embryo. Thus, at least some of the association 
of disease with pregnancy failure represents disruption of reproductive function after the 
early period of pregnancy. In another experiment reported in the same paper, the uterus 
was flushed at Day 5 or 6 after first AI postpartum to evaluate effect of disease on 
fertilization of the oocyte and development of the early embryo. Occurrence of uterine 
disease and other, non-uterine types of diseases were associated with reduced cleavage 
rate and proportion of embryos classified as live or high quality.  Effects of disease on 
elongation of the embryo at Day 15 and 16 of gestation, and accumulation of the 
antiluteolytic hormone interferon-tau, in the uterus was also assessed. Previous 
occurrence of either uterine disease or non-uterine disease were associated with smaller 
conceptuses and lower accumulation of interferon-tau in the uterine lumen. Taken 
together, results indicate that disease can affect a wide variety of events in early 
pregnancy that are required for successful gestation.  
 
VARIATION IN IMMUNE FUNCTION IS AN IMPORTANT DETERMINANT OF 
POSTPARTUM DISEASE 
 
Studies discussed in the previous section provide compelling evidence that a cow 
that experiences one or more diseases in the postpartum period is at risk for suboptimal 
reproduction including delayed breeding, reduced pregnancy rate and increased rate of 
pregnancy loss.  Whether or not a cow develops a disease in the postpartum period 
depends on a variety of factors including the nature of pathogen exposure (number and 
virulence), function of physiological and nutritional systems important for development of 
specific diseases like gastrointestinal problems and lameness, and characteristics of the 
immune system. The importance of the nature of pathogen exposure is evident because 
while most cows have bacteria present in the uterus after calving, there are differences 
in the microbiome of cows whose uterus remains healthy and those that develop metritis 
or endometritis (Bicalho et al., 2017ab).  
 
Experiments on genetic variation in the function of the immune system have 
revealed the importance of the immune system for establishment of specific diseases in 
the postpartum period. In particular, Millard and colleagues at the University of Guelph 
have used measurements of antibody production and delayed hypersensitivity reactions 
in the skin to estimate genetic breeding value for antibody-mediated immune function, 
cell-mediated immune function and overall immune response (based on the first two 
measurements).  For some diseases, including mastitis, displaced abomasum, and 
retained fetal membranes, cows with low estimated breeding value (EBV) for overall 
immune response were most likely to experience disease (Table 2).  
 
Table 2.  Disease incidence (percent) in cows classified based on estimated breeding 
value (EBV) for overall immune response (Thompson-Crispi et al., 2012).   
Disease Low EBV for 
immune response  
(n=153) 
Average EBV for immune 
response (n=407) 
High EBV for 
immune response 
(n=139) 
Mastitis 25.7ab 29.0a 19.4b 
Metritis 7.2 4.7 4.3 
Ketosis 5.9 5.7 5.8 
Displaced 
abomasum 
5.8a 1.7b 3.6ab 
Retained fetal 
membranes 
13.1a 5.9b 5.0b 
ab Means with different superscripts differ (P<0.05).  
 
There are also indications that numbers or function of polymorphonuclear 
leukocytes (PMN) in the blood are important for adequate resistance to disease. Cows 
that subsequently developed metritis or endometritis in the postpartum period had less 
functional neutrophils than cows that did not develop uterine disease (Hammon et al., 
2006).  Treatment of periparturient cows with the granulocyte colony stimulating factor 
(G-CSF) to increase PMN numbers and function reduced the incidence of clinical mastitis 
(Canning et al., 2017; Ruiz et al., 2017). Similarly, supporting PMN function by feeding  
OmniGen-AF reduced incidence of udder edema and tended to reduce incidence of 
mastitis (Nace et al., 2014).   
 
PRELIMINARY STUDIES TO TEST WHETHER ENHANCING IMMUNE 
FUNCTION CAN IMPROVE REPRODUCTION 
 
Given that postpartum disease is associated with reduced reproductive function 
and that immune function is one determinant of whether a cow experiences an adverse 
health effect, it follows that it may be feasible to improve reproductive function in lactating 
cows by enhancing immune function. There are many potential approaches for doing so 
including regulating calcium metabolism postpartum (Vieira-Neto et al., 2017), improving 
energy balance (Lacasse et al., 2017), feeding nutritional supplements that enhance 
immune function (Nace et al., 2014) or by provision of biologicals like G-CSF that regulate 
components of the immune system (Canning et al., 2017; Ruiz et al., 2017). 
 
It is too soon to know whether regulating immune function to improve reproduction 
will be effective but the idea is worth pursuing because reduction in disease incidence 
can also have other beneficial effects on the productivity and longevity of the cow.  The 
only large-scale studies on effects of immune stimulants on reproductive function have 
been performed using G-CSF (Canning et al., 2017, Ruiz et al., 2017). In those studies, 
treated cows were injected with G-CSF at 7 days before expected calving and again within 
24 hours after calving.  The effects of this treatment on reproductive function were mixed.  
In the experiment by Canning et al. (2017), 320 cows per treatment were enrolled (80 
cows per treatment at each of 4 dairies). Treatment with G-CSF reduced the incidence of 
mastitis but not of dystocia, metritis, lameness, pneumonia or a combination of ketosis, 
left displaced abomasum or peritonitis. A greater percent of cows treated with G-CSF 
were detected in estrus by day 80 postpartum (95.4% vs 90.6%) but there was no effect 
of treatment on pregnancy rate at first service (42.6% vs 38.2%). The study by Ruiz et al. 
(2017) involved 10,238 cows in 17 herds. Incidence of mastitis was reduced by G-CSF 
but there was no significant effect on incidence of retained placenta. Surprisingly, G-CSF 
increased incidence of metritis from 8.4 to 9.8%.  Cows treated with G-CSF were 5.8% 
more likely to be inseminated in the first 100 days after calving than control cows.   
 
These studies with G-CSF have not yet made clear whether reproductive function 
is amenable to change through immune stimulation. It may be that activation of PMN 
function at other times postpartum or promotion of function of other components of the 
immune system would be more effective at increasing fertility than that cause by injection 
of G-CSF or other agents around the time of calving. More studies are warranted.  
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